Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 2014-08-27 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 2019-03-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 2014-08-27 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 2023-03-30 |
Hyung Kim
BRD | Director/Board Member | 40 | 2024-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| +0.93% | +6.97% | +62.83% | +67.97% | 57.28B | |
| -1.92% | +6.03% | +43.68% | +84.56% | 54.99B | |
| -0.46% | -1.29% | +3.28% | +422.58% | 23.18B | |
| -2.97% | -2.35% | -22.03% | -16.54% | 22.59B | |
| -0.36% | +5.73% | +30.99% | -3.58% | 20.46B | |
| -1.34% | +0.51% | +25.02% | -30.27% | 17.56B | |
| -1.44% | +5.67% | +32.54% | +544.11% | 15.67B | |
| -1.30% | -5.02% | +165.62% | +291.37% | 14.46B | |
| -0.50% | -0.98% | +23.62% | +178.38% | 13.92B | |
| Average | -3.98% | +1.28% | +40.62% | +170.95% | 26.68B | |
| Weighted average by Cap. | -0.87% | +2.10% | +41.18% | +135.69% |
Employees
4
